Protocol Ledger

NCT04284839 · Phase III · RECRUITING

The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial

Interventional Phase III clinical trial protocol NCT04284839 sponsored by Population Health Research Institute in Cardiovascular and Thrombosis, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2021-07-18 Enrollment: 3,500 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT04284839
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)3,500 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)3 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04284839
Protocol FieldVerified Registry Value
NCT IdentifierNCT04284839
Consolidated Lead SponsorPopulation Health Research Institute
Therapeutic Condition CohortCardiovascular and Thrombosis
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment3,500 participants (ESTIMATED)
Registered Start Date2021-07-18
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT04284839
Hospital Research SiteLocationSite Profile
St Vincent's Hospital MelbourneFitzroy, AustraliaOpen Hospital Dossier ->
University of Alberta HospitalEdmonton, CanadaOpen Hospital Dossier ->
Toronto General HospitalToronto, CanadaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI